Publications

2026

Douxfils J, Chabbert-Buffet N, Creinin MD, Didembourg M, Dogné JM, Foidart JM, Gaspard U, Heikinheimo O, Lidegaard Ø, Locquet M, Morimont L, Raskin L, Gemzell Danielsson K, Kopp-Kallner H. Critical assessment of a prolonged-release EE/DNG contraceptive safety analysis. Eur J Contracept Reprod Health Care. 2026 Feb 17:1-4.

Raskin L, Boretti E, Douxfils J, Beaudart C. Patient Preferences Regarding Menopausal Symptoms and Treatments: A Systematic Review of Quantitative Stated-Preference Studies. Patient. 2026 Feb 10.

Didembourg M, Morimont L, De Gottal E, Douxfils J. The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum. Thromb Res. 2026 Jan:257:109561.

2025

Morimont L, Creinin MD, Gaspard U, Foidart JM, Douxfils J. Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives. Res Pract Thromb Haemost. 2025 Dec 6;10(1):103285.

Douxfils J, Didembourg M, Maitrot-Mantelet L, Chapron C, Descamps P, Tremollières F, Chabbert-Buffet N. Venous Thromboembolism Risk Associated With Relugolix-estradiol-norethisterone Acetate Combination Therapy. J Endocr Soc. 2025 Nov 22;10(2):bvaf190.

Douxfils J, Morimont L, Flerin N, Gaspard U, Foidart JM. Evaluation of the safety profile of prolonged-release EE/DNG oral contraceptives: a critical appraisal. Gynecol Endocrinol. 2025 Dec 31;41(1):2571648.

Douxfils J. Cost-effective screening strategy to prevent venous thromboembolism in combined oral contraceptive users. Front Endocrinol (Lausanne). 2025 Jun 12;16:1559162.

Creinin MD, Foidart JM, Gemzell-Danielsson K, Flerin NC, Kubba A, Gaspard U, Douxfils J. Estetrol/Drospirenone Safety in a Population with Cardiovascular Risk Factors. Contraception. 2025 Jun:146:110861.

Didembourg M, Locquet M, Raskin L, Tchimchoua BT, Dogné JM, Beaudart C, Douxfils J. Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis of the Eudravigilance database. Contraception. 2025 Feb;142:110727.